Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Office of Clinical Science made permanent

Executive Summary

The search for a permanent director of the Office of Clinical Science will begin in the next several weeks. David Lepay, MD/PhD, will continue to serve as acting director (1"The Pink Sheet" Aug. 14, p. 14). The newly permanent office will be supported by a Human Subject Protection/Good Clinical Practices Steering Committee, to be chaired by the OCS and include senior policy representatives from each of the Centers, the Office of Regulatory Affairs, the Office of Policy and the Office of Chief Counsel

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036785

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel